Publication Name	World Journal of Diabetes
Manuscript ID	20577
Country	United States

Received	2015-06-11 08:42
Peer-Review Started	2015-06-11 21:57
To Make the First Decision	2015-08-16 14:45
Return for Revision	2015-08-24 15:15
Revised	2015-08-25 07:02
Second Decision	2015-09-15 15:43
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief	2015-09-28 17:55
Articles in Press	2015-09-28 17:55
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2015-10-16 10:49
Publish the Manuscript Online	2015-10-26 10:17

ISSN	1948-9358 (online)
Open Access	This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright	© The Author(s) 2015. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Medicine, Research & Experimental
Manuscript Type	Review
Article Title	Erythropoietin and diabetes mellitus
Manuscript Source	Invited Manuscript
All Author List	Kenneth Maiese
Funding Agency and Grant Number	Funding Agency Grant Number American Diabetes Association American Heart Association NIH NIEHS NIH NIA NIH NINDS NIH ARRA to Maiese K
Corresponding Author	Kenneth Maiese, MD, Cellular and Molecular Signaling, 125 Main Street, Newark, NJ 07101, United States. wntin75@yahoo.com
Key Words	Protein kinase B; AMP activated protein kinase; Apoptosis; Autophagy; Forkhead; Metabolism; Factors of the O class; Diabetes mellitus; Erythropoietin; Stem cells; Silent mating type information regulation 2 homolog 1; Oxidative stress; Wnt1 inducible signaling pathway protein 1; Wnt
Core Tip	Erythropoietin and the downstream signaling pathways of this cytokine that include protein kinase B, mechanistic target of rapamycin, Wnt signaling, Factors of the O class proteins, silent mating type information regulation 2 homolog 1 (Saccharomyces cerevisiae), and AMP activated protein kinase offer new avenues for the development of novel treatments for diabetes mellitus and the complications of this disease.
Publish Date	2015-10-26 10:17
Citation	Maiese K. Erythropoietin and diabetes mellitus. World J Diabetes 2015; 6(14): 1259-1273
URL	http://www.wjgnet.com/1948-9358/full/v6/i14/1259.htm
DOI	http://dx.doi.org/10.4239/wjd.v6.i14.1259

Full Article (PDF)	WJD-6-1259.pdf
Full Article (Word)	WJD-6-1259.doc
Manuscript File	20577-Review.doc
Answering Reviewers	20577-Answering reviewers.pdf
Audio Core Tip	20577-Audio core tip.mp3
Conflict-of-Interest Disclosure Form	20577-Conflict-of-interest statement.pdf
Copyright License Agreement	20577-Copyright assignment.pdf
Peer-review Report	20577-Peer-review(s).pdf
Scientific Misconduct Check	20577-Scientific misconduct check.pdf
Scientific Editor Work List	20577-Scientific editor work list.pdf